A Singapore government officer posted to the United Kingdom has been counselled and warned after leaving his kids at home alone. Bored as well as broke? We’ve got good news for you. This November, ...

Multinational medical companies reached collaborations with local healthcare authorities, hospitals and businesses at the ongoing 7th China International Import Expo held in Shanghai to jointly build ...

Massachusetts-based Ring Therapeutics has partnered with Singapore’s A*STAR and SERI to advance gene therapy using its ...

Follow us on Facebook and join our Telegram channel for the latest updates. Singapore has published its 32-page national anti-money laundering (AML) strategy, as part of continuing efforts to maintain ...

Powered by PandaOmics, Insilico’s proprietary generative biology AI platform, the joint R&D team comprising Insilico Medicine and Sanofi colleagues focused on highly novel targets known to be ...

French pharma giant Sanofi is selling off its consumer healthcare business Opella. US-based investment firm Clayton, Dubilier & Rice (CD&R) is to take a controlling 50% stake, while Sanofi will retain ...

(RTTNews) - Sanofi announced that Beyfortus (nirsevimab) will be broadly available for babies born in Ontario, Quebec, Nunavut, Northwest Territories, and the Yukon this fall. The administration ...

Whatever the case, having access to 24-hour money changers in Singapore can be a real lifesaver. Whether you're a local getting ready for a last-minute trip or a visitor landing in Singapore at an ...

Sanofi (NASDAQ:SNY) shares gained on Friday after the French pharma giant exceeded analysts' estimates with its Q3 thanks mainly to earlier-than-anticipated vaccine sales and a 22% YoY rise in ...

Korean-styled burgers are coming to Singapore. Lotteria, a South Korean burger chain, is partnering with F&B and hospitality group Katrina Group to start “multiple Lotteria outlets across Singapore”, ...

Despite Merck & Co. homing in on approval for its infant respiratory syncytial virus (RSV) antibody clesrovimab, Sanofi—which last year won its own nod for its AstraZeneca-partnered RSV ...